Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Maio

Showing results (21-30 of 418) with videos related to

Pageof 42
Sort By:
Translational Lung Cancer Research|July 23, 2021
First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysisFrancesco Facchinetti, Massimo Di Maio, Fabiana Perrone, et al.
Lung Cancer (Amsterdam, Netherlands)|March 31, 2009
Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?Paolo Maione, Antonio Rossi, Massimo Di Maio, et al.
Nature Reviews. Clinical Oncology|January 21, 2016
Patient-reported outcomes in the evaluation of toxicity of anticancer treatmentsMassimo Di Maio, Ethan Basch, Jane Bryce, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 25, 2014
A meta-analysis of the impact of bronchial stump coverage on the risk of bronchopleural fistula after pneumonectomyMassimo Di Maio, Francesco Perrone, Claude Deschamps, et al.
Future Oncology (London, England)|April 28, 2018
Thymidine phosphorylase: the unforeseen driver in colorectal cancer treatment?Marco Tampellini, Paolo Bironzo, Massimo Di Maio, et al.
Frontiers in Oncology|May 7, 2019
Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-AnalysisAlfredo Addeo, Giuseppe Luigi Banna, Giulio Metro, et al.
Critical Reviews in Oncology/Hematology|May 22, 2019
Target therapies in recurrent or metastatic head and neck cancer: state of the art and novel perspectives. A systematic reviewLeonardo Muratori, Anna La Salvia, Paola Sperone, et al.
Critical Reviews in Oncology/Hematology|June 9, 2015
Papillary renal cell carcinoma: A review of the current therapeutic landscapeGiulia Courthod, Marcello Tucci, Massimo Di Maio, et al.
Expert Opinion on Investigational Drugs|August 13, 2008
153Sm: its use in multiple myeloma and report of a clinical experienceElisabetta Abruzzese, Francesco Iuliano, Malgorzata Monika Trawinska, et al.
Journal of Cellular Physiology|May 17, 2005
Trying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancerMassimo Di Maio, Cesare Gridelli, Nicola Normanno, et al.
Pageof 42

Showing results (21-30 of 418) with videos related to

Sort By:
Pageof 42
Translational Lung Cancer Research|July 23, 2021
First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysisFrancesco Facchinetti, Massimo Di Maio, Fabiana Perrone, et al.
Lung Cancer (Amsterdam, Netherlands)|March 31, 2009
Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?Paolo Maione, Antonio Rossi, Massimo Di Maio, et al.
Nature Reviews. Clinical Oncology|January 21, 2016
Patient-reported outcomes in the evaluation of toxicity of anticancer treatmentsMassimo Di Maio, Ethan Basch, Jane Bryce, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 25, 2014
A meta-analysis of the impact of bronchial stump coverage on the risk of bronchopleural fistula after pneumonectomyMassimo Di Maio, Francesco Perrone, Claude Deschamps, et al.
Future Oncology (London, England)|April 28, 2018
Thymidine phosphorylase: the unforeseen driver in colorectal cancer treatment?Marco Tampellini, Paolo Bironzo, Massimo Di Maio, et al.
Frontiers in Oncology|May 7, 2019
Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-AnalysisAlfredo Addeo, Giuseppe Luigi Banna, Giulio Metro, et al.
Critical Reviews in Oncology/Hematology|May 22, 2019
Target therapies in recurrent or metastatic head and neck cancer: state of the art and novel perspectives. A systematic reviewLeonardo Muratori, Anna La Salvia, Paola Sperone, et al.
Critical Reviews in Oncology/Hematology|June 9, 2015
Papillary renal cell carcinoma: A review of the current therapeutic landscapeGiulia Courthod, Marcello Tucci, Massimo Di Maio, et al.
Expert Opinion on Investigational Drugs|August 13, 2008
153Sm: its use in multiple myeloma and report of a clinical experienceElisabetta Abruzzese, Francesco Iuliano, Malgorzata Monika Trawinska, et al.
Journal of Cellular Physiology|May 17, 2005
Trying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancerMassimo Di Maio, Cesare Gridelli, Nicola Normanno, et al.
Pageof 42